跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Clindafer - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Clindafer
Approved
STANDARD
Clindafer
Maxitech Pharma (Pvt.) Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
20654de3858c07b8
Company
Maxitech Pharma (Pvt.) Ltd.
Type
Standard
Approval Details
Approval Id
20654de3858c07b8
Drug Approval Philippines Name
Clindafer
Product Name
Clindafer
Registration Number
DRP-14203-03
Brand Name
Clindafer
Generic Name
Clindamycin (as phosphate)
Dosage Form
Solution for Injection (IM/IV)
Dosage Strength
150 mg/mL (300 mg/2mL)
Manufacturer
Maxitech Pharma (Pvt.) Ltd.
Importer
Accesspoint International Trading Inc.
Distributor
Ferjan Philippines Inc.
Issuance Date
24 December 2024
Expiry Date
20 July 2028
Pharmacologic Category
Antibacterial (Lincosamide)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
20654de3858c07b8
Type
Standard
Back to Philippines FDA Approvals